Evidence map›Paper›PMID 25820263›Full record

ArticleThe EMBO journal2015

Telomerase abrogates aneuploidy-induced telomere replication stress, senescence and cell depletion.

Jitendra K Meena, Aurora Cerutti, Christine Beichler, Yohei Morita, Christopher Bruhn, Mukesh Kumar, Johann M Kraus, Michael R Speicher, Zhao-Qi Wang, Hans A Kestler and 3 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in The EMBO journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 86 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. The Hallmarks of Aneuploidy in Cancer and Congenital Syndromes.Annual review of genomics and human genetics · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Modeling specific aneuploidies: from karyotype manipulations to biological insights.Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology · 2023
    Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Detection of Telomeric DNA:RNA Hybrids Using TeloDRIP-qPCR.International journal of molecular sciences · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Jitendra K MeenaLeibniz Institute of Age Research, Fritz Lipmann Institute e.V., Jena, Germany.
Aurora CeruttiIFOM Foundation-FIRC Institute of Molecular Oncology Foundation, Milan, Italy.
Christine BeichlerInstitute of Human Genetics, Medical University of Graz, Graz, Austria.
Yohei MoritaLeibniz Institute of Age Research, Fritz Lipmann Institute e.V., Jena, Germany.
Christopher BruhnLeibniz Institute of Age Research, Fritz Lipmann Institute e.V., Jena, Germany.
Mukesh KumarInstitute of Experimental Cancer Research, University of Ulm, Ulm, Germany.
Johann M KrausMedical Systems Biology Unit, Ulm University, Ulm, Germany.
Michael R SpeicherInstitute of Human Genetics, Medical University of Graz, Graz, Austria.
Zhao-Qi WangLeibniz Institute of Age Research, Fritz Lipmann Institute e.V., Jena, Germany.
Hans A KestlerLeibniz Institute of Age Research, Fritz Lipmann Institute e.V., Jena, Germany Medical Systems Biology Unit, Ulm University, Ulm, Germany.
Fabrizio d'Adda di FagagnaIFOM Foundation-FIRC Institute of Molecular Oncology Foundation, Milan, Italy Istituto di Genetica Molecolare, Consiglio Nazionale delle Ricerche, Pavia, Italy.
Cagatay GünesLeibniz Institute of Age Research, Fritz Lipmann Institute e.V., Jena, Germany cguenes@fli-leibniz.de klrudolph@fli-leibniz.de.
Karl Lenhard RudolphLeibniz Institute of Age Research, Fritz Lipmann Institute e.V., Jena, Germany cguenes@fli-leibniz.de klrudolph@fli-leibniz.de.
Leibniz Institute on Aging - Fritz Lipmann Institute (FLI) · DEUniversität Ulm · DEFIRC Institute of Molecular Oncology · ITMedical University of Graz · AT

Funding

Austrian Science Fund FWF P 23284European Research Council 322726Telethon GGP12059
6 · The paper itself

Abstract

The causal role of aneuploidy in cancer initiation remains under debate since mutations of euploidy-controlling genes reduce cell fitness but aneuploidy strongly associates with human cancers. Telomerase activation allows immortal growth by stabilizing telomere length, but its role in aneuploidy survival has not been characterized. Here, we analyze the response of primary human cells and murine hematopoietic stem cells (HSCs) to aneuploidy induction and the role of telomeres and the telomerase in this process. The study shows that aneuploidy induces replication stress at telomeres leading to telomeric DNA damage and p53 activation. This results in p53/Rb-dependent, premature senescence of human fibroblast, and in the depletion of hematopoietic cells in telomerase-deficient mice. Endogenous telomerase expression in HSCs and enforced expression of telomerase in human fibroblasts are sufficient to abrogate aneuploidy-induced replication stress at telomeres and the consequent induction of premature senescence and hematopoietic cell depletion. Together, these results identify telomerase as an aneuploidy survival factor in mammalian cells based on its capacity to alleviate telomere replication stress in response to aneuploidy induction.

Indexed as

AneuploidyAnimalsCellular SenescenceDNA ReplicationHematopoietic Stem CellsHumansMiceTelomeraseTelomereTumor Suppressor Protein p53TelomeraseTumor Suppressor Protein p53aneuploidyreplication stresssenescencetelomerasetelomere

Identifiers

PMID25820263
PMCPMC4491997
OpenAlexW1990909310

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.